Xiangjian Luo

4.7k citations
71 papers · 2.9k indexed · 2 hit papers · h-index 31
Topics
Cancer, Hypoxia, and Metabolism (20 papers)Viral-associated cancers and disorders (17 papers)RNA modifications and cancer (15 papers)

In The Last Decade

Xiangjian Luo

66 papers receiving 2.9k citations

Hit Papers

Emerging roles of lipid metabolism in cancer metastasis201720262020202320172021100200300400

Peers

Xiangjian Luo
Comparison fields: 5 of 111
  • Molecular Biology 1.8k
  • Cancer Research 1.2k
  • Oncology 726
  • Epidemiology 387
  • Immunology 353
Replace Rui Liu with:
Rui Liu China
Yun‐Yong Park South Korea
George G. Chen Hong Kong
Xin Wen China
Karim Bensaad United Kingdom
Sahng Wook Park South Korea
Hai‐long Piao China
Pixu Liu China
Linda Oyang China
Xiangjian Luo relative to Rui Liu China Rui Liu's profile →
Citations per field
00.5×2.9×
Rui Liu · 1×
Citations per year

Countries citing papers authored by Xiangjian Luo

Since Specialization
Citations

This map shows the geographic impact of Xiangjian Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangjian Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangjian Luo more than expected).

Fields of papers citing papers by Xiangjian Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangjian Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangjian Luo. The network helps show where Xiangjian Luo may publish in the future.

Co-authorship network of co-authors of Xiangjian Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangjian Luo. A scholar is included among the top collaborators of Xiangjian Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangjian Luo. Xiangjian Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 10
4 6
5 6
6 7
7 6
8 12
9 14
10 23
11 82
12 32
13 62
14
Emerging roles of lipid metabolism in cancer metastasisbreakdown →
499
15 101
16 47
17 16
18 35
19 66
20 7

About Xiangjian Luo

Xiangjian Luo is a scholar working on Cancer Research, Oncology and Biochemistry, having authored 71 papers that have together received 2.9k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (20 papers), Viral-associated cancers and disorders (17 papers) and RNA modifications and cancer (15 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (726 citations) and Molecular Biology (1.8k citations). Xiangjian Luo has collaborated with scholars based in China, United States and Saudi Arabia. Frequent co-authors include Ya Cao, Ann M. Bode, Min Tang, Can Cheng, Namei Li, Lifang Yang, Zheqiong Tan, Jianmin Hu, Chaoliang Liao and Zigang Dong. Their work appears in journals such as Scientific Reports, FEBS Letters and International Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026